Literature DB >> 33672087

Medicinal Use of Testosterone and Related Steroids Revisited.

Jan Tauchen1, Michal Jurášek2, Lukáš Huml2, Silvie Rimpelová3.   

Abstract

Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.

Entities:  

Keywords:  aging; androgen receptor; antiandrogens; longevity; medicinal natural products; performance-enhancing drugs; selective androgen receptor modulators; testosterone

Mesh:

Substances:

Year:  2021        PMID: 33672087      PMCID: PMC7919692          DOI: 10.3390/molecules26041032

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  97 in total

1.  The steroid story of Jenapharm: from the late 1940s to the early 1970s.

Authors:  S Schwarz; D Onken; A Schubert
Journal:  Steroids       Date:  1999-07       Impact factor: 2.668

Review 2.  Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.

Authors:  Michael L Mohler; Casey E Bohl; Amanda Jones; Christopher C Coss; Ramesh Narayanan; Yali He; Dong Jin Hwang; James T Dalton; Duane D Miller
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

3.  Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140.

Authors:  Chris P Miller; Maysoun Shomali; C Richard Lyttle; Louis St L O'Dea; Hillary Herendeen; Kyla Gallacher; Dottie Paquin; Dennis R Compton; Bishwabhusan Sahoo; Sean A Kerrigan; Matthew S Burge; Michael Nickels; Jennifer L Green; John A Katzenellenbogen; Alexei Tchesnokov; Gary Hattersley
Journal:  ACS Med Chem Lett       Date:  2010-12-02       Impact factor: 4.345

Review 4.  Testosterone prohormone supplements.

Authors:  Gregory A Brown; Matthew Vukovich; Douglas S King
Journal:  Med Sci Sports Exerc       Date:  2006-08       Impact factor: 5.411

Review 5.  Emerging medication for the treatment of male hypogonadism.

Authors:  Giovanni Corona; Giulia Rastrelli; Linda Vignozzi; Mario Maggi
Journal:  Expert Opin Emerg Drugs       Date:  2012-05-21       Impact factor: 4.191

6.  Studies on the in vivo metabolism of methylstenbolone and detection of novel long term metabolites for doping control analysis.

Authors:  Thomas Piper; Gregor Fusshöller; Wilhelm Schänzer; Andreas Lagojda; Dirk Kuehne; Mario Thevis
Journal:  Drug Test Anal       Date:  2019-12-08       Impact factor: 3.345

7.  Hormonal therapy of breast cancer with special reference to Masteril therapy.

Authors:  M B Bennett; P Helman; P Palmer
Journal:  S Afr Med J       Date:  1975-11-15

8.  Tetrahydrogestrinone: discovery, synthesis, and detection in urine.

Authors:  Don H Catlin; Michael H Sekera; Brian D Ahrens; Borislav Starcevic; Yu-Chen Chang; Caroline K Hatton
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

9.  Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

Authors:  C H Chesnut; J L Ivey; H E Gruber; M Matthews; W B Nelp; K Sisom; D J Baylink
Journal:  Metabolism       Date:  1983-06       Impact factor: 8.694

10.  [Pathophysiology of aplastic anemia and its treatment with methenolone enanthate].

Authors:  K Krug
Journal:  Z Gesamte Inn Med       Date:  1980-11-15
View more
  2 in total

Review 1.  Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches.

Authors:  Lukáš Huml; Jan Tauchen; Silvie Rimpelová; Barbora Holubová; Oldřich Lapčík; Michal Jurášek
Journal:  Sensors (Basel)       Date:  2021-12-21       Impact factor: 3.576

Review 2.  Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models.

Authors:  Mélanie Bourque; Denis Soulet; Thérèse Di Paolo
Journal:  Androg Clin Res Ther       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.